NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Biophytis SA (NASDAQ: BPTS)

 
BPTS Technical Analysis
2
As on 9th Jun 2023 BPTS STOCK Price closed @ 2.80 and we RECOMMEND Buy for LONG-TERM with Stoploss of 2.00 & Strong Sell for SHORT-TERM with Stoploss of 4.53 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

BPTSSTOCK Price

Open 2.80 Change Price %
High 2.80 1 Day 0.41 17.15
Low 2.39 1 Week 0.39 16.18
Close 2.80 1 Month -0.60 -17.65
Volume 1206 1 Year -2.32 -45.31
52 Week High 5.54 | 52 Week Low 0.35
 
NASDAQ USA Most Active Stocks
TSLA 244.40 4.06%
TTOO 0.07 -12.50%
SOFI 8.18 0.74%
FFIE 0.33 6.45%
PONO 1.72 2.38%
AMD 124.92 3.20%
IDEX 0.06 0.00%
NKLA 0.70 14.75%
AMZN 123.43 -0.66%
AAPL 180.96 0.22%
 
NASDAQ USA Top Gainers Stocks
IDRA 8.64 1909.30%
REDU 3.41 1075.86%
CTXRW 0.14 600.00%
NDRAW 0.03 200.00%
METXW 0.05 150.00%
GLSPT 33.43 138.62%
BCAC 22.71 125.30%
JCIC 22.08 116.68%
AURCW 0.04 100.00%
NOVVW 0.02 100.00%
 
NASDAQ USA Top Losers Stocks
OTIC 0.01 -91.67%
PTRAW 0.23 -89.59%
PTIXW 0.01 -66.67%
AGBAW 0.02 -66.67%
MLACW 0.02 -60.00%
MILEW 0.06 -53.85%
RCRTW 0.02 -50.00%
LOTZW 0.01 -50.00%
GSMGW 0.01 -50.00%
DKDCW 0.01 -50.00%
 
 
BPTS
Daily Charts
BPTS
Intraday Charts
Whats New @
Bazaartrend
BPTS
Free Analysis
 
BPTS Important Levels Intraday
RESISTANCE3.59
RESISTANCE3.34
RESISTANCE3.18
RESISTANCE3.02
SUPPORT2.58
SUPPORT2.42
SUPPORT2.26
SUPPORT2.01
 
BPTS Forecast May 2024
4th UP Forecast6.48
3rd UP Forecast5.3
2nd UP Forecast4.57
1st UP Forecast3.84
1st DOWN Forecast1.76
2nd DOWN Forecast1.03
3rd DOWN Forecast0.3
4th DOWN Forecast-0.88
 
BPTS Weekly Forecast
4th UP Forecast4.28
3rd UP Forecast3.81
2nd UP Forecast3.51
1st UP Forecast3.22
1st DOWN Forecast2.38
2nd DOWN Forecast2.09
3rd DOWN Forecast1.79
4th DOWN Forecast1.32
 
BPTS Forecast2024
4th UP Forecast13.51
3rd UP Forecast10.08
2nd UP Forecast7.95
1st UP Forecast5.83
1st DOWN Forecast-0.23
2nd DOWN Forecast-2.35
3rd DOWN Forecast-4.48
4th DOWN Forecast-7.91
 
 
BPTS Other Details
Segment EQ
Market Capital 83234344.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
BPTS Address
BPTS
 
BPTS Latest News
 
Your Comments and Response on Biophytis SA
 
BPTS Business Profile
Biophytis SA, a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases and the treatment of severe respiratory failure in patients suffering from COVID-19. Its therapeutics focuses on targeting and activating key biological resilience pathways that could protect against and counteract the effects of the multiple biological and environmental stresses that lead to age-related diseases. The company's lead drug candidate, Sarconeos (BIO101), is an orally administered small molecule in development for the treatment of neuromuscular diseases, including sarcopenia and Duchenne muscular dystrophy (DMD). Its second drug candidate, Macuneos (BIO201), is an orally administered small molecule in development for the treatment of retinal diseases, including dry ager elated macular degeneration (AMD) and Stargardt disease. Biophytis SA has a collaboration agreement with AFM-Telethon for the development of its Sarconeos (BIO101) for the treatment of DMD. The company was incorporated in 2006 and is based in Paris, France. Address: Sorbonne University, Paris, France, 75005
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service